Toll Free: 1-888-928-9744

JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the JCR Pharmaceuticals Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of JCR Pharmaceuticals Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of JCR Pharmaceuticals Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of JCR Pharmaceuticals Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the JCR Pharmaceuticals Co., Ltd.'s pipeline products

Reasons to buy

- Evaluate JCR Pharmaceuticals Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of JCR Pharmaceuticals Co., Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the JCR Pharmaceuticals Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of JCR Pharmaceuticals Co., Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of JCR Pharmaceuticals Co., Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of JCR Pharmaceuticals Co., Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
JCR Pharmaceuticals Co., Ltd. Snapshot 5
JCR Pharmaceuticals Co., Ltd. Overview 5
Key Information 5
Key Facts 5
JCR Pharmaceuticals Co., Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
JCR Pharmaceuticals Co., Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
JCR Pharmaceuticals Co., Ltd. - Pipeline Products Glance 14
JCR Pharmaceuticals Co., Ltd. - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
JCR Pharmaceuticals Co., Ltd. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
JCR Pharmaceuticals Co., Ltd. - Drug Profiles 16
JR-031 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
darbepoetin alfa 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
JR-032 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
JR-051 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
JR-101 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
JCR Pharmaceuticals Co., Ltd. - Pipeline Analysis 22
JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Target 22
JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Route of Administration 23
JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Molecule Type 24
JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action 25
JCR Pharmaceuticals Co., Ltd. - Dormant Projects 26
JCR Pharmaceuticals Co., Ltd. - Company Statement 27
JCR Pharmaceuticals Co., Ltd. - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31
List of Tables
JCR Pharmaceuticals Co., Ltd., Key Information 5
JCR Pharmaceuticals Co., Ltd., Key Facts 5
JCR Pharmaceuticals Co., Ltd. - Pipeline by Indication, 2014 7
JCR Pharmaceuticals Co., Ltd. - Pipeline by Stage of Development, 2014 8
JCR Pharmaceuticals Co., Ltd. - Monotherapy Products in Pipeline, 2014 9
JCR Pharmaceuticals Co., Ltd. - Partnered Products in Pipeline, 2014 10
JCR Pharmaceuticals Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 11
JCR Pharmaceuticals Co., Ltd. - Out-Licensed Products in Pipeline, 2014 12
JCR Pharmaceuticals Co., Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2014 13
JCR Pharmaceuticals Co., Ltd. - Phase II, 2014 14
JCR Pharmaceuticals Co., Ltd. - Preclinical, 2014 15
JCR Pharmaceuticals Co., Ltd. - Pipeline by Target, 2014 22
JCR Pharmaceuticals Co., Ltd. - Pipeline by Route of Administration, 2014 23
JCR Pharmaceuticals Co., Ltd. - Pipeline by Molecule Type, 2014 24
JCR Pharmaceuticals Co., Ltd. - Pipeline Products by Mechanism of Action, 2014 25
JCR Pharmaceuticals Co., Ltd. - Dormant Developmental Projects,2014 26
JCR Pharmaceuticals Co., Ltd., Other Locations 28
JCR Pharmaceuticals Co., Ltd., Subsidiaries 29 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify